News Contact Us Careers Get E-Mail alerts Search

You are now leaving www.admabiologics.com

The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?

Yes No

News

See below for our most recent and archived news events.

Click below for current and archived news related to the company.

ADMA Biologics Announces Proposed $75 Million Public Offering of Common Stock

Feb 06, 2020 4:06pm EST

ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2019 Revenues and Provides 2020 Strategic Outlook

Jan 09, 2020 7:00am EST

ADMA Biologics Enters Into a Manufacturing and Supply Agreement to Produce and Sell Plasma-Derived Intermediate Fractions

Jan 07, 2020 7:00am EST

ADMA Biologics Added to NASDAQ Biotechnology Index

Dec 17, 2019 7:08am EST

ADMA Biologics to Present at Jefferies 2019 London Healthcare Conference

Nov 13, 2019 7:08am EST

ADMA Biologics Reports Third Quarter 2019 Financial Results and Highlights Recent Company Progress

Nov 06, 2019 5:02pm EST

ADMA Biologics Announces Acceptance to the Plasma Protein Therapeutics Association

Nov 04, 2019 7:08am EST

ADMA Biologics Named Company of the Year by BioFlorida

Oct 22, 2019 7:48am EDT

ADMA Biologics Announces First Commercial Sales of ASCENIV™

Oct 21, 2019 7:48am EDT

ADMA Biologics Announces Publication of an Article Describing the Manufacturing Process Optimization for its Commercial Products BIVIGAM® and ASCENIV™ in the Peer Reviewed Journal Immunotherapy

Oct 17, 2019 7:29am EDT

1...
2
3
4
5
6
7
8
9
10
11
...22